Christian S. Schade - 07 Feb 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role: Director
Signature: /s/ Barbara Chan as Attorney-in-Fact for Christian S. Schade
Issuer symbol: OMGAQ
Transactions as of: 07 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 09 Feb 2024, 16:57:49 UTC
Previous filing: 12 Jul 2023
Next filing: 13 May 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OMGA	Stock Option (Right to Buy)	Award	$0	+512,848		$0.000000	512,848	07 Feb 2024	Common Stock	512,848	$3.59	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested and became exercisable as to 14.28% of the underlying shares on February 7, 2024 and vests and will become exercisable in thirty-six (36) substantially equal monthly installments thereafter, such that the option shall be fully vested and exercisable on February 7, 2027, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.

Content

The option vested and became exercisable as to 14.28% of the underlying shares on February 7, 2024 and vests and will become exercisable in thirty-six (36) substantially equal monthly installments thereafter, such that the option shall be fully vested and exercisable on February 7, 2027, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.